MARKET

CELG-RT

CELG-RT

Bristol-Myers Squibb Company Celegne Contingent Value Rights
NYSE
0.0423
-0.0009
-2.08%
Closed 15:50 06/21 EDT
OPEN
0.0400
PREV CLOSE
0.0432
HIGH
0.0423
LOW
0.0400
VOLUME
19.18K
TURNOVER
0
52 WEEK HIGH
0.1400
52 WEEK LOW
0.0116
MARKET CAP
30.09M
P/E (TTM)
-0.0136
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at CELG RT last week (0610-0614)?
Weekly Report · 5d ago
Weekly Report: what happened at CELG RT last week (0603-0607)?
Weekly Report · 06/10 09:14
Weekly Report: what happened at CELG RT last week (0527-0531)?
Weekly Report · 06/03 09:14
Weekly Report: what happened at CELG RT last week (0520-0524)?
Weekly Report · 05/27 09:14
Weekly Report: what happened at CELG RT last week (0513-0517)?
Weekly Report · 05/20 09:14
Weekly Report: what happened at CELG RT last week (0506-0510)?
Weekly Report · 05/13 09:14
Weekly Report: what happened at CELG RT last week (0429-0503)?
Weekly Report · 05/06 09:15
Weekly Report: what happened at CELG RT last week (0422-0426)?
Weekly Report · 04/29 09:16
More
About CELG-RT
Bristol-Myers Squibb Company is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor (CAR-T) cell therapies. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are used as well. Biologics are administered to patients through injections or by intravenous infusion. Its in-line products include Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Yervoy, Sprycel, Reblozyl, Opdualag, Abecma, Zeposia, and others. The Company's product pipeline includes Krazati, MRTX1719, RYZ101, KarXT, ORM-6151, and Repotrectinib.

Webull offers Bristol-Myers Squibb Co stock information, including NYSE: CELG RT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CELG RT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CELG-RT stock methods without spending real money on the virtual paper trading platform.